SCN5A Mutations Associate with Arrhythmic Dilated Cardiomyopathy and Commonly Localize to the Voltage-sensing Mechanism

Overview

Journal J Am Coll Cardiol

Specialty Cardiology & Vascular Diseases

Date 2011 May 21

PMID 21596231

Citations 99

Authors

William P McNair

Gianfranco Sinagra

Matthew R G Taylor

Andrea di Lenarda

Debra A Ferguson

Ernesto E Salcedo

Dobromir Slavov

Xiao Zhu

John H Caldwell

Luisa Mestroni

Affiliations

Soon will be listed here.

Abstract

Objectives: The aim of this study was to discern the role of the cardiac voltage-gated sodium ion channel SCN5A in the etiology of dilated cardiomyopathy (DCM).

Background: Dilated cardiomyopathy associates with mutations in the SCN5A gene, but the frequency, phenotype, and causative nature of these associations remain the focus of ongoing investigation.

Methods: Since 1991, DCM probands and family members have been enrolled in the Familial Cardiomyopathy Registry and extensively evaluated by clinical phenotype. Genomic deoxyribonucleic acid samples from 338 individuals among 289 DCM families were obtained and screened for SCN5A mutations by denaturing high-performance liquid chromatography and sequence analysis.

Results: We identified 5 missense SCN5A mutations among our DCM families, including novel mutations E446K, F1520L, and V1279I, as well as previously reported mutations D1275N and R222Q. Of 15 SCN5A mutation carriers in our study, 14 (93%) manifested arrhythmia: supraventricular arrhythmia (13 of 15), including sick sinus syndrome (5 of 15) and atrial fibrillation (9 of 15), ventricular tachycardia (5 of 15), and conduction disease (9 of 15).

Conclusions: Mutations in SCN5A were detected in 1.7% of DCM families. Two-thirds (6 of 9) of all reported DCM mutations in SCN5A localize to the highly conserved homologous S3 and S4 transmembrane segments, suggesting a shared mechanism of disruption of the voltage-sensing mechanism of this channel leading to DCM. Not surprisingly, SCN5A mutation carriers show a strong arrhythmic pattern that has clinical and diagnostic implications.

Citing Articles

Mechanisms underlying dilated cardiomyopathy associated with FKBP12 deficiency.

Hanna A, Chang T, Ho K, Yee R, Walker W, Agha N J Gen Physiol. 2024; 157(1).

PMID: 39661086 PMC: 11633665. DOI: 10.1085/jgp.202413583.

The many faces of SCN5A pathogenic variants: from channelopathy to cardiomyopathy.

Vouloagkas I, Agbariah A, Zegkos T, Gossios T, Tziomalos G, Parcharidou D Heart Fail Rev. 2024; 30(1):247-256.

PMID: 39465469 DOI: 10.1007/s10741-024-10459-x.

What Do We Know about Peripartum Cardiomyopathy? Yesterday, Today, Tomorrow.

Lasica R, Asanin M, Vukmirovic J, Maslac L, Savic L, Zdravkovic M Int J Mol Sci. 2024; 25(19).

PMID: 39408885 PMC: 11477285. DOI: 10.3390/ijms251910559.

Pathophysiology of dilated cardiomyopathy: from mechanisms to precision medicine.

Gigli M, Stolfo D, Merlo M, Sinagra G, Taylor M, Mestroni L Nat Rev Cardiol. 2024; 22(3):183-198.

PMID: 39394525 DOI: 10.1038/s41569-024-01074-2.

Causal association between 1400 metabolites and dilated cardiomyopathy: a bidirectional two-sample Mendelian randomization analysis.

Zeng X, Zeng Q, Wang X, Li K, Wu J, Luo J Front Endocrinol (Lausanne). 2024; 15:1423142.

PMID: 39329103 PMC: 11424463. DOI: 10.3389/fendo.2024.1423142.

References

Rook M, Bezzina Alshinawi C, Groenewegen W, van Gelder I, van Ginneken A, Jongsma H . Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome. Cardiovasc Res. 2000; 44(3):507-17. DOI: 10.1016/s0008-6363(99)00350-8. View

Long S, Campbell E, MacKinnon R . Crystal structure of a mammalian voltage-dependent Shaker family K+ channel. Science. 2005; 309(5736):897-903. DOI: 10.1126/science.1116269. View

Aggarwal S, Mackinnon R . Contribution of the S4 segment to gating charge in the Shaker K+ channel. Neuron. 1996; 16(6):1169-77. DOI: 10.1016/s0896-6273(00)80143-9. View

Gellens M, George Jr A, Chen L, Chahine M, Horn R, Barchi R . Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel. Proc Natl Acad Sci U S A. 1992; 89(2):554-8. PMC: 48277. DOI: 10.1073/pnas.89.2.554. View

Greenlee P, Anderson J, Lutz J, Lindsay A, Hagan A . Familial automaticity-conduction disorder with associated cardiomyopathy. West J Med. 1986; 144(1):33-41. PMC: 1306503. View

Kane G, Liu X, Yamada S, Olson T, Terzic A . Cardiac KATP channels in health and disease. J Mol Cell Cardiol. 2005; 38(6):937-43. PMC: 2736958. DOI: 10.1016/j.yjmcc.2005.02.026. View

Chen J, Chien K . Complexity in simplicity: monogenic disorders and complex cardiomyopathies. J Clin Invest. 1999; 103(11):1483-5. PMC: 408378. DOI: 10.1172/JCI7297. View

Olson T, Keating M . Mapping a cardiomyopathy locus to chromosome 3p22-p25. J Clin Invest. 1996; 97(2):528-32. PMC: 507047. DOI: 10.1172/JCI118445. View

Nguyen T, Wang D, Rhodes T, George Jr A . Divergent biophysical defects caused by mutant sodium channels in dilated cardiomyopathy with arrhythmia. Circ Res. 2007; 102(3):364-71. DOI: 10.1161/CIRCRESAHA.107.164673. View

10.

Mestroni L, Maisch B, McKenna W, Schwartz K, Charron P, Rocco C . Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. Eur Heart J. 1999; 20(2):93-102. DOI: 10.1053/euhj.1998.1145. View

11.

Makita N, Shirai N, Wang D, Sasaki K, George Jr A, Kanno M . Cardiac Na(+) channel dysfunction in Brugada syndrome is aggravated by beta(1)-subunit. Circulation. 2000; 101(1):54-60. DOI: 10.1161/01.cir.101.1.54. View

12.

Chen Q, Kirsch G, Zhang D, Brugada R, Brugada J, Brugada P . Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature. 1998; 392(6673):293-6. DOI: 10.1038/32675. View

13.

Schmitt J, Kamisago M, Asahi M, Li G, Ahmad F, Mende U . Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science. 2003; 299(5611):1410-3. DOI: 10.1126/science.1081578. View

14.

Hershberger R, Parks S, Kushner J, Li D, Ludwigsen S, Jakobs P . Coding sequence mutations identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 patients with familial or idiopathic dilated cardiomyopathy. Clin Transl Sci. 2009; 1(1):21-6. PMC: 2633921. DOI: 10.1111/j.1752-8062.2008.00017.x. View

15.

Makita N, Shirai N, Nagashima M, Matsuoka R, Yamada Y, Tohse N . A de novo missense mutation of human cardiac Na+ channel exhibiting novel molecular mechanisms of long QT syndrome. FEBS Lett. 1998; 423(1):5-9. DOI: 10.1016/s0014-5793(98)00033-7. View

16.

Rozen S, Skaletsky H . Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol. 1999; 132:365-86. DOI: 10.1385/1-59259-192-2:365. View

17.

Tiso N, Stephan D, Nava A, Bagattin A, Devaney J, Stanchi F . Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet. 2001; 10(3):189-94. DOI: 10.1093/hmg/10.3.189. View

18.

Seoh S, Sigg D, Papazian D, Bezanilla F . Voltage-sensing residues in the S2 and S4 segments of the Shaker K+ channel. Neuron. 1996; 16(6):1159-67. DOI: 10.1016/s0896-6273(00)80142-7. View

19.

Hershberger R, Lindenfeld J, Mestroni L, Seidman C, Taylor M, Towbin J . Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline. J Card Fail. 2009; 15(2):83-97. DOI: 10.1016/j.cardfail.2009.01.006. View

20.

Long S, Campbell E, MacKinnon R . Voltage sensor of Kv1.2: structural basis of electromechanical coupling. Science. 2005; 309(5736):903-8. DOI: 10.1126/science.1116270. View